Related Experiment Videos

Cost-analysis of management strategies for children with vesico-ureteric reflux

L Nicklasson1, S Högård

  • 1Department of Community Medicine, Lund University, Malmö, Sweden.

Insights

Subureteric injection is the most cost-effective treatment for pediatric vesico-ureteric reflux, followed by antibacterial prophylaxis. Neo-implantation is the most expensive option for treating this condition in children.

Area of Science:

  • Pediatric Urology
  • Health Economics
  • Cost-Effectiveness Analysis

Background:

  • Vesico-ureteric reflux (VUR) is a common condition in children, potentially leading to kidney infections and damage.
  • Treatment options include surgical correction (neo-implantation, subureteric injection) and long-term medical management (antibacterial prophylaxis).
  • Economic evaluations are crucial for comparing the cost-effectiveness of different VUR treatment strategies.

Purpose of the Study:

  • To conduct an economic evaluation comparing three primary treatment strategies for pediatric vesico-ureteric reflux.
  • To determine the cost-effectiveness of subureteric injection, antibacterial prophylaxis, and neo-implantation from a community perspective.

Main Methods:

  • A cost-analysis approach was employed, focusing on direct and indirect costs.
  • Data for surgical strategies were collected from four Swedish hospitals.
  • Data for the prophylactic strategy were gathered via a survey of 31 hospitals.

Main Results:

  • Subureteric injection was ranked as the most cost-effective strategy, with costs ranging from SEK 25,000-28,000 (SEK 26,000-36,000 for bilateral cases).
  • Antibacterial prophylaxis was the second most cost-effective option (SEK 16,000-36,000).
  • Neo-implantation presented the highest costs, ranging from SEK 65,000-90,000 (SEK 72,000-95,000 for bilateral cases).

Conclusions:

  • Subureteric injection offers the most favorable economic profile for managing pediatric vesico-ureteric reflux.
  • Antibacterial prophylaxis provides a moderate cost-effective alternative.
  • Neo-implantation is significantly more costly compared to the other evaluated treatment modalities for VUR in children.

Related Concept Videos